Cargando…
Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
1. Background: We sought to determine acute and subacute changes in cardiac function after proton beam (PBT) and photon beam (PhT) radiotherapy (RT) using conventional and two-dimensional speckle tracking echocardiography (2D-STE) in patients with malignant breast and thoracic tumors. 2. Methods: Be...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607871/ https://www.ncbi.nlm.nih.gov/pubmed/37887865 http://dx.doi.org/10.3390/jcdd10100418 |
_version_ | 1785127645406560256 |
---|---|
author | Abbasi, Muhannad Aboud Bruno, Giulia Di Stefano, Cristina Garcia Bello, Laura Laack, Nadia N. Corbin, Kimberly S. Whitaker, Thomas J. Pellikka, Patricia A. Mutter, Robert W. Villarraga, Hector R. |
author_facet | Abbasi, Muhannad Aboud Bruno, Giulia Di Stefano, Cristina Garcia Bello, Laura Laack, Nadia N. Corbin, Kimberly S. Whitaker, Thomas J. Pellikka, Patricia A. Mutter, Robert W. Villarraga, Hector R. |
author_sort | Abbasi, Muhannad Aboud |
collection | PubMed |
description | 1. Background: We sought to determine acute and subacute changes in cardiac function after proton beam (PBT) and photon beam (PhT) radiotherapy (RT) using conventional and two-dimensional speckle tracking echocardiography (2D-STE) in patients with malignant breast and thoracic tumors. 2. Methods: Between March 2016 and March 2017, 70 patients with breast or thoracic cancer were prospectively enrolled and underwent transthoracic echocardiography with comprehensive strain analysis at pretreatment, mid-treatment, end of treatment, and 3 months after RT. 3. Results: PBT was used to treat 44 patients; PhT 26 patients. Mean ± SD age was 55 ± 12 years; most patients (93%) were women. The median (interquartile range) of the mean heart dose was lower in the PBT than the PhT group (47 [27–79] vs. 217 [120–596] cGy, respectively; p < 0.001). Ejection fraction did not change in either group. Only the PhT group had reduced systolic tissue Doppler velocities at 3 months. 2D-STE showed changes in endocardial and epicardial longitudinal, radial, and circumferential early diastolic strain rate (SRe) in patients undergoing PhT (global longitudinal SRe, pretreatment vs. end of treatment (p = 0.04); global circumferential SRe, pretreatment vs. at 3-month follow-up (p = 0.003); global radial SRe, pretreatment vs. at 3-month follow-up (p = 0.02) for endocardial values). Epicardial strain values decreased significantly only in patients treated with PhT. Patients in the PhT group had a significant decrease in epicardial global longitudinal systolic strain rate (GLSRs) (epicardial GLSRs, at baseline vs. at end of treatment [p = 0.009]) and in GCSRe and GRSRe (epicardial GCSRe, at baseline vs. at 3-month follow-up (p = 0.02); epicardial GRSRe, at baseline vs. at 3-month follow-up (p = 0.03)) during treatment and follow-up. No changes on 2D-STE were detected in the PBT group. 4. Conclusions: Patients who underwent PhT but not PBT had reduced tissue Doppler velocities and SRe values during follow-up, suggesting early myocardial relaxation abnormalities. PBT shows promise as a cardiac-sparing RT technology. |
format | Online Article Text |
id | pubmed-10607871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106078712023-10-28 Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study Abbasi, Muhannad Aboud Bruno, Giulia Di Stefano, Cristina Garcia Bello, Laura Laack, Nadia N. Corbin, Kimberly S. Whitaker, Thomas J. Pellikka, Patricia A. Mutter, Robert W. Villarraga, Hector R. J Cardiovasc Dev Dis Article 1. Background: We sought to determine acute and subacute changes in cardiac function after proton beam (PBT) and photon beam (PhT) radiotherapy (RT) using conventional and two-dimensional speckle tracking echocardiography (2D-STE) in patients with malignant breast and thoracic tumors. 2. Methods: Between March 2016 and March 2017, 70 patients with breast or thoracic cancer were prospectively enrolled and underwent transthoracic echocardiography with comprehensive strain analysis at pretreatment, mid-treatment, end of treatment, and 3 months after RT. 3. Results: PBT was used to treat 44 patients; PhT 26 patients. Mean ± SD age was 55 ± 12 years; most patients (93%) were women. The median (interquartile range) of the mean heart dose was lower in the PBT than the PhT group (47 [27–79] vs. 217 [120–596] cGy, respectively; p < 0.001). Ejection fraction did not change in either group. Only the PhT group had reduced systolic tissue Doppler velocities at 3 months. 2D-STE showed changes in endocardial and epicardial longitudinal, radial, and circumferential early diastolic strain rate (SRe) in patients undergoing PhT (global longitudinal SRe, pretreatment vs. end of treatment (p = 0.04); global circumferential SRe, pretreatment vs. at 3-month follow-up (p = 0.003); global radial SRe, pretreatment vs. at 3-month follow-up (p = 0.02) for endocardial values). Epicardial strain values decreased significantly only in patients treated with PhT. Patients in the PhT group had a significant decrease in epicardial global longitudinal systolic strain rate (GLSRs) (epicardial GLSRs, at baseline vs. at end of treatment [p = 0.009]) and in GCSRe and GRSRe (epicardial GCSRe, at baseline vs. at 3-month follow-up (p = 0.02); epicardial GRSRe, at baseline vs. at 3-month follow-up (p = 0.03)) during treatment and follow-up. No changes on 2D-STE were detected in the PBT group. 4. Conclusions: Patients who underwent PhT but not PBT had reduced tissue Doppler velocities and SRe values during follow-up, suggesting early myocardial relaxation abnormalities. PBT shows promise as a cardiac-sparing RT technology. MDPI 2023-10-04 /pmc/articles/PMC10607871/ /pubmed/37887865 http://dx.doi.org/10.3390/jcdd10100418 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Abbasi, Muhannad Aboud Bruno, Giulia Di Stefano, Cristina Garcia Bello, Laura Laack, Nadia N. Corbin, Kimberly S. Whitaker, Thomas J. Pellikka, Patricia A. Mutter, Robert W. Villarraga, Hector R. Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study |
title | Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study |
title_full | Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study |
title_fullStr | Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study |
title_full_unstemmed | Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study |
title_short | Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study |
title_sort | detection of early myocardial dysfunction by imaging biomarkers in cancer patients undergoing photon beam vs. proton beam radiotherapy: a prospective study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607871/ https://www.ncbi.nlm.nih.gov/pubmed/37887865 http://dx.doi.org/10.3390/jcdd10100418 |
work_keys_str_mv | AT abbasimuhannadaboud detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy AT brunogiulia detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy AT distefanocristina detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy AT garciabellolaura detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy AT laacknadian detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy AT corbinkimberlys detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy AT whitakerthomasj detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy AT pellikkapatriciaa detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy AT mutterrobertw detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy AT villarragahectorr detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy |